United Therapeutics (UTHR) Tops Q2 EPS by 5c; Reaffirms Outlook

July 25, 2013 7:55 AM

United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $1.52, $0.05 better ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found